Scholar Rock Holding (SRRK) Other Operating Expenses (2024 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Other Operating Expenses of -$3000.0 for Q1 2026, up 99.97% year-over-year from -$1500.3 in Q1 2025, and up 99.98% quarter-over-quarter from -$12.8 million in Q4 2025.
Scholar Rock Holding (SRRK) Other Operating Expenses (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 99.97% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$47.1 million (down 79.08% YoY), while the FY2025 annual figure was -$56.1 million, down 150.55% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$3000.0, up from -$12.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was -$3000.0 in Q1 2026, with the low at -$19.4 million in Q3 2025.
- The 3-year median for Other Operating Expenses is -$6.2 million (2024), against an average of -$8.7 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses slumped 281.56% in 2025, then soared 99.97% in 2026.
- Scholar Rock Holding's Other Operating Expenses stood at -$6.2 million in 2024, then tumbled by 106.96% to -$12.8 million in 2025, then surged by 99.98% to -$3000.0 in 2026.
- Business Quant data shows SRRK's Other Operating Expenses at -$3000.0 in Q1 2026, -$12.8 million in Q4 2025, and -$19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.60 Mn |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -12.76 Mn |
| Sep 30, 2025 | -19.43 Mn |
| Jun 30, 2025 | -14.95 Mn |
| Mar 31, 2025 | -8.94 Mn |
| Dec 31, 2024 | -6.16 Mn |
| Sep 30, 2024 | -5.09 Mn |
| Jun 30, 2024 | -6.13 Mn |
| Mar 31, 2024 | -5.00 Mn |